Pharmafile Logo
Pharmafocus logo
Advanced Search

drugs

Showing 15 posts of 771 posts found.

Head of Sandoz UK becomes BGMA chair

May 30, 2018
Manufacturing and Production, Research and Development British Generic Manufacturers Association, biotech, drugs, pharma, pharmaceutical

Tim de Gavre has been announced as the new chair for the British Generic Manufacturers Association (BGMA), a position he …

News
novato-south-campus

BioMarin receives FDA nod for its would-be blockbuster

May 25, 2018
Medical Communications, Sales and Marketing BioMarin, biotech, drugs, pharma, pharmaceutical

BioMarin is confident that its newly approved treatment for phenylketonuria (PKU) is set to become a blockbuster and it’s priced the …

News
breast_cancer_scan

Breast cancer screening scandal potentially involves even more women

May 25, 2018
Medical Communications Jeremy Hunt, NHS, biotech, drugs, pharma, pharmaceutical

The news broke at the start of the month that a number of women who should have been invited to …

News
prothena-37882-2

Prothena guts workforce by more than half, after trial failure

May 25, 2018
Medical Communications Neil Woodford, Prothena, Roche, biotech, drugs, pharma, pharmaceutical

Prothena Therapeutics has acted drastically by slashing staff numbers by more than half, after the failure of two pivotal trials …

News
john_crowley_edit

John Crowley speaks on drug development and the FDA

May 24, 2018
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amicus Therapeutics, John Crowley, biotech, drugs, pharma, pharmaceutical

Pharmafocus spoke to John Crowley, CEO of Amicus Therapeutics, about his highly unusual career in the pharmaceutical and biotech industries.

Feature
astellas_tokyo_copy

Astellas begins major restructure, as 600 jobs slashed

May 24, 2018
Medical Communications Astellas, biotech, drugs, pharma, pharmaceutical

Astellas, under the direction of new CEO, Kenji Yasukawa, has unveiled a major new restructure, ahead of a difficult looking …

News
nhs_parliament_2_4

Report calls for tax rises to fund ailing NHS

May 24, 2018
Medical Communications IFS, NHS, UK government, biotech, drugs, pharma, pharmaceutical

A report published by the Institute for Fiscal Studies (IFS) has stressed that UK funding into the NHS needs to …

News
merck_and_co

MSD’s Keytruda scores impressive first-line lung cancer data

May 24, 2018
Research and Development, Sales and Marketing MSD, biotech, drugs, keytruda, pharma, pharmaceutical

MSD Keytruda has enjoyed the most success of the PD-1/L1 therapies in clinical trials recently and it’s rapidly cementing its …

News
handshake_2

Vifor Fresenius snap up rights to Cara’s itch therapy

May 23, 2018
Research and Development, Sales and Marketing Cara Therapeutics, Vifor Fresenius, biotech, drugs, pharma, pharmaceutical

The joint partnership between Vifor Pharma and Fresenius Medical Care, Vifor Fresenius, has put down $50 in upfront cash and …

News
obese-3011213_960_720

World heading towards 25% of total population being obese

May 23, 2018
Research and Development WHO, biotech, drugs, obesity, pharma, pharmaceutical

The latest global research paints a bleak picture of future global public health, predicting that almost a quarter of the …

News
takeda_tokyo_hq

Takeda begins to shore up finances with $280m divestment

May 23, 2018
Research and Development, Sales and Marketing Takeda, biotech, drugs, pharma, pharmaceutical

Much has already been written about Takeda and its massive financial stretch to pull in the Shire acquisition, in the …

News

NHS Trust harnesses AI to speed up treatment

May 22, 2018
Manufacturing and Production, Medical Communications AI, NHS, biotech, drugs, pharma, pharmaceutical

The Royal Liverpool and Broadgreen University Hospitals NHS Trust has teamed up with a provider of AI systems to introduce …

News
brothers-457237_960_720

The cause of the most common form of childhood cancer found

May 22, 2018
Manufacturing and Production, Research and Development biotech, drugs, leukaemia, pharma, pharmaceutical

Professor Mel Greaves, of The Institute of Cancer Research, has spent 30 years uncovering what is behind the mysterious rise …

News
pills_shot

Nabriva closes in on bringing new class of antibiotic to market

May 22, 2018
Manufacturing and Production, Sales and Marketing Antibiotics, Nabriva Therapeutics, biotech, drugs, pharma, pharmaceutical

Nabriva Therapeutics, a biotech based in Dublin, Ireland, has announced positive Phase 3 data for its antibiotic, lefamulin, which could …

News
gilead-sciences

Gilead expands operations in Cork, Ireland

May 21, 2018
Manufacturing and Production, Sales and Marketing Gilead, Ireland, biotech, drugs, pharma, pharmaceutical

Gilead has unveiled the expansion of its Cork manufacturing site, involved in the creation of its treatments for HIV and …

News

Latest content

AbbVie invests €150m in new R&D facility in Germany

May 3, 2024

AstraZeneca shares positive interim results from phase 3 lymphoma trial

May 3, 2024

Merck shares data from phase 3 trial of Keytruda for gastric cancers

May 2, 2024

Verona Pharma to share phase 3 COPD trial data at ATS 2024

May 2, 2024

Beckman Coulter Life Sciences and Watchmaker Genomics enter collaboration

May 1, 2024